Szumska Joanna, Qatato Maria, Rehders Maren, Führer Dagmar, Biebermann Heike, Grandy David K, Köhrle Josef, Brix Klaudia
Department of Life Sciences and Chemistry, Jacobs University Bremen, Bremen, Germany.
Department of Endocrinology and Metabolism and Division of Laboratory Research, University of Duisburg-Essen, Essen, Germany.
Eur Thyroid J. 2015 Sep;4(Suppl 1):30-41. doi: 10.1159/000434717. Epub 2015 Jun 10.
The trace amine-associated receptor 1 (Taar1) is one member of the Taar family of G-protein-coupled receptors (GPCR) accepting various biogenic amines as ligands. It has been proposed that Taar1 mediates rapid, membrane-initiated effects of thyronamines, the endogenous decarboxylated and deiodinated relatives of the classical thyroid hormones T4 and T3.
Although the physiological actions of thyronamines in general and 3-iodothyronamine (T1AM) in particular are incompletely understood, studies published to date suggest that synthetic T1AM-activated Taar1 signaling antagonizes thyromimetic effects exerted by T3. However, the location of Taar1 is currently unknown.
To fill this gap in our knowledge we employed immunofluorescence microscopy and a polyclonal antibody to detect Taar1 protein expression in thyroid tissue from Fisher rats, wild-type and taar1-deficient mice, and in the polarized FRT cells.
With this approach we found that Taar1 is expressed in the membranes of subcellular compartments of the secretory pathway and on the apical plasma membrane of FRT cells. Three-dimensional analyses further revealed Taar1 immunoreactivity in cilial extensions of postconfluent FRT cell cultures that had formed follicle-like structures.
The results suggest Taar1 transport along the secretory pathway and its accumulation in the primary cilium of thyrocytes. These findings are of significance considering the increasing interest in the role of cilia in harboring functional GPCR. We hypothesize that thyronamines can reach and activate Taar1 in thyroid follicular epithelia by acting from within the thyroid follicle lumen, their potential site of synthesis, as part of a nonclassical mechanism of thyroid autoregulation.
痕量胺相关受体1(Taar1)是G蛋白偶联受体(GPCR)的Taar家族成员之一,可接受多种生物胺作为配体。有人提出,Taar1介导了甲状腺胺的快速、膜起始效应,甲状腺胺是经典甲状腺激素T4和T3的内源性脱羧和脱碘衍生物。
尽管甲状腺胺尤其是3-碘甲状腺胺(T1AM)的生理作用尚未完全明确,但迄今为止发表的研究表明,合成的T1AM激活的Taar1信号传导可拮抗T3发挥的拟甲状腺效应。然而,Taar1的定位目前尚不清楚。
为填补这一知识空白,我们采用免疫荧光显微镜和多克隆抗体来检测Fisher大鼠、野生型和taar1基因缺陷小鼠的甲状腺组织以及极化的FRT细胞中Taar1蛋白的表达。
通过这种方法,我们发现Taar1表达于分泌途径亚细胞区室的膜上以及FRT细胞的顶端质膜上。三维分析进一步揭示,在形成卵泡样结构的汇合后FRT细胞培养物的纤毛延伸中存在Taar1免疫反应性。
结果表明Taar1沿分泌途径运输并在甲状腺细胞的初级纤毛中积累。考虑到人们对纤毛在携带功能性GPCR中的作用越来越感兴趣,这些发现具有重要意义。我们推测,甲状腺胺可以从甲状腺滤泡腔(其潜在的合成部位)内起作用,作为甲状腺自身调节的一种非经典机制的一部分,到达并激活甲状腺滤泡上皮中的Taar1。